Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: evidence for loss of apoptotic activity in lymphocytes
about
Molecular and functional properties of P2X receptors--recent progress and persisting challengesNeural progenitor cell death is induced by extracellular ATP via ligation of P2X7 receptor.The role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite controlContraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7The role of the P2X₇ receptor in infectious diseases.IL-11 regulates autoimmune demyelinationContribution of pannexin1 to experimental autoimmune encephalomyelitis.Testing the role of P2X7 receptors in the development of type 1 diabetes in nonobese diabetic miceLoss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitisLipopolysaccharide inhibits the channel activity of the P2X7 receptor.P2Y2R deficiency attenuates experimental autoimmune uveitis developmentP2X7 on Mouse T Cells: One Channel, Many FunctionsRoles of white matter in central nervous system pathophysiologies.P2 receptors and immunity.Systems-based medicine approaches to understand and treat complex diseases. The example of multiple sclerosis.Ion channels in innate and adaptive immunityP2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis.Purinergic receptors as potential therapeutic targets in Alzheimer's disease.VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown.P2X7 receptors in oligodendrocytes: a novel target for neuroprotection.Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events.Physiological and pathological functions of P2X7 receptor in the spinal cord.Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation.Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis.Glutamate and ATP signalling in white matter pathology.Emerging role of extracellular nucleotides and adenosine in multiple sclerosis.Neurotransmitter signaling in the pathophysiology of microglia.Purinergic signalling and immune cells.P2X and P2Y receptors—role in the pathophysiology of the nervous system.Central nervous system myeloid cells as drug targets: current status and translational challenges.The microglial ATP-gated ion channel P2X7 as a CNS drug target.Mitochondrial superoxide generation enhances P2X7R-mediated loss of cell surface CD62L on naive human CD4+ T lymphocytes.Diadenosine homodinucleotide products of ADP-ribosyl cyclases behave as modulators of the purinergic receptor P2X7.Characterization of ATP-induced cell death in the GL261 mouse glioma.Ca(2+) influx in T cells: how many ca(2+) channels?Pannexin1 channels act downstream of P2X 7 receptors in ATP-induced murine T-cell death.Purinergic P2X7 receptor regulates lung surfactant secretion in a paracrine manner.P2X7 R-mediated Ca(2+) -independent d-serine release via pannexin-1 of the P2X7 R-pannexin-1 complex in astrocytes.Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease.The role of the purinergic P2X7 receptor in inflammation.
P2860
Q24617046-8CFC6C0B-6258-4269-88B2-19B70B9C0DDFQ33413400-AD0DAF15-28BE-4747-A1E5-706D8ED0DAACQ33689420-9FBE2387-C4A8-49CD-A79D-B140EA7957ACQ33799011-BB99C399-030F-4B25-B63B-1DC7426533E1Q34079146-0CCFB0C3-5AAE-4EED-84C6-AE7C167866F9Q34522058-92BC5059-A2AA-445E-AB96-32D4FA5B2772Q34864822-0E032CF4-97C1-4E4A-B53C-1EBA525C5EABQ34982496-4609FB0A-600E-4841-9D7C-A64D9A771043Q35063750-92463FDE-C475-4919-8976-EA4A7CE1AA92Q35214735-44A61EF6-1763-44C3-95C6-DD7C71F68AD1Q35563346-84591429-CA5E-4012-8F7D-DADDF4EABC08Q35621886-659A2CA8-AD97-4D7F-9437-EBEAA6B4CEACQ35846494-114FD5DB-CBA4-41DF-8B00-F152CF75FAA7Q36446067-C27E9502-BEBD-459C-8ED4-F2E026BDB1D7Q36687908-ED943C1F-E280-48E1-8A7D-7C916A22B640Q36769825-31358A8E-AE32-43EA-85D4-EACF1AC79656Q36842750-9068E029-FCD5-40B4-88AA-0962037B5D0FQ36844881-3F6236C9-7D17-42C0-B00D-2DB20E78712AQ37100939-141AAF2D-D550-4E72-9013-518F81E76B64Q37243989-22FF2AE0-7AC2-4AB2-B87C-5BFCE7A58E35Q37348374-5E1A6FD1-9E8F-4F59-87F3-37DA1CB78A0CQ37389355-24EF3443-B3A0-4C10-A575-BCABFFE86BC4Q37586481-1F02DB7D-A22F-4055-99D6-831BB47000FCQ37826775-83175AA3-09F5-4165-A085-69AB1204AB11Q37830727-C049B77A-D1E1-4E93-A470-89BB59CB2134Q37906358-90B43E34-C39F-4826-B462-55633EF95F82Q38102686-7CF3EA9B-3103-443B-896C-34125B880620Q38263455-C6C84362-34D2-47AC-AE27-45134BBB2FE5Q38296527-56B6C42E-7560-453F-B558-66D6A4A3D63EQ38658658-2E160E6C-E1BC-4AC4-A0A7-7584D99D1885Q38843107-C5AEF327-5964-4AF5-BE39-6FFD6CC8586BQ39210353-571E7EBA-A26D-4B94-BEA5-1D5F05DACDBFQ39708017-6C927A68-DDF0-4A5C-952B-C1FD1765F659Q39752599-57CABBA1-7161-46DE-AB09-C9C25F7FA751Q40028875-F733EDB2-0D70-4B4D-86CD-42D87C4E9944Q40401050-28F4655F-D946-464C-AE8A-9ECF2C6AB142Q42007181-E5A9959F-DCEB-4EAF-999A-62EEB84298BBQ42472092-A89AB740-3D85-4FD9-ABD4-C71EF7E9AD28Q42487631-735F620E-0395-457A-9F6E-8C3C1B363240Q42876676-B5F1A544-0262-4DA4-A954-708D2C3EC210
P2860
Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: evidence for loss of apoptotic activity in lymphocytes
description
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im März 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/03/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/03/01)
@nl
наукова стаття, опублікована в березні 2006
@uk
مقالة علمية (نشرت في مارس 2006)
@ar
name
Exacerbation of experimental a ...... ptotic activity in lymphocytes
@ast
Exacerbation of experimental a ...... ptotic activity in lymphocytes
@en
Exacerbation of experimental a ...... ptotic activity in lymphocytes
@nl
type
label
Exacerbation of experimental a ...... ptotic activity in lymphocytes
@ast
Exacerbation of experimental a ...... ptotic activity in lymphocytes
@en
Exacerbation of experimental a ...... ptotic activity in lymphocytes
@nl
prefLabel
Exacerbation of experimental a ...... ptotic activity in lymphocytes
@ast
Exacerbation of experimental a ...... ptotic activity in lymphocytes
@en
Exacerbation of experimental a ...... ptotic activity in lymphocytes
@nl
P921
P1476
Exacerbation of experimental a ...... ptotic activity in lymphocytes
@en
P2093
Celia F. Brosnan
Lanfen Chen
P304
P356
10.4049/JIMMUNOL.176.5.3115
P407
P577
2006-03-01T00:00:00Z